QuidelOrtho Corp QDEL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
-
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
-
QuidelOrtho to Participate in Upcoming Investor Conferences
-
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
QuidelOrtho Reports Second Quarter 2024 Financial Results
-
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600
-
QuidelOrtho to Report Second Quarter 2024 Financial Results
-
QuidelOrtho's stock loses about a third of its value after earnings miss
Trading Information
- Previous Close Price
- $43.45
- Day Range
- $42.92–43.91
- 52-Week Range
- $29.74–75.86
- Bid/Ask
- $41.88 / $44.84
- Market Cap
- $2.94 Bil
- Volume/Avg
- 427,839 / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 17.94
- Price/Sales
- 1.03
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 7,100
- Website
- https://www.quidelortho.com
Comparables
Valuation
|
Metric
|
QDEL
|
603658
|
688468
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.94 | 21.83 | 21.05 |
Price/Book Value | 0.93 | 3.41 | 2.05 |
Price/Sales | 1.03 | 6.08 | 6.16 |
Price/Cash Flow | 8.30 | 15.34 | 14.42 |
Price/Earnings
QDEL
603658
688468
Financial Strength
|
Metric
|
QDEL
|
603658
|
688468
|
|---|---|---|---|
Quick Ratio | 0.62 | 0.99 | 4.71 |
Current Ratio | 1.44 | 2.71 | 5.48 |
Interest Coverage | −9.65 | 57.12 | 111.54 |
Quick Ratio
QDEL
603658
688468
Profitability
|
Metric
|
QDEL
|
603658
|
688468
|
|---|---|---|---|
Return on Assets (Normalized) | 1.12% | 11.37% | 7.46% |
Return on Equity (Normalized) | 2.03% | 15.28% | 9.59% |
Return on Invested Capital (Normalized) | 3.71% | 14.14% | 7.98% |
Return on Assets
QDEL
603658
688468
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Kxcvjjr | Xknhhd | $196.0 Bil | |||
| Stryker Corp
SYK
| Tdrvwxqsw | Zpzc | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Hwtwsmlq | Dwmhvmb | $124.5 Bil | |||
| Medtronic PLC
MDT
| Qhgqdwx | Tmdkrw | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Prfnbzxhn | Nyzgf | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Whd | Kyhl | $30.2 Bil | |||
| DexCom Inc
DXCM
| Kxdxqnskfl | Ghxhh | $27.3 Bil | |||
| Steris PLC
STE
| Mptmtshm | Rzckws | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Bvzrvybf | Pkm | $21.3 Bil | |||
| Insulet Corp
PODD
| Qtwdslnys | Rqfsht | $16.1 Bil |
United States